⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.

Official Title: A European Randomised Phase 3 Study to Assess the Efficacy and Safety of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance

Study ID: NCT01310894

Conditions

Prostate Cancer

Interventions

TOOKAD® Soluble

Study Description

Brief Summary: The aims of this study are: * to assess the impact of TOOKAD® Soluble-Vascular Targeted Photodynamic Therapy (VTP) on the rate of absence of definite cancer using patients on active surveillance as a comparison (co-primary objective A) and * to determine the difference in rate of treatment failure associated with observed progression of disease from low risk prostate cancer to moderate or higher risk prostate cancer in men who undergo TOOKAD® Soluble-VTP compared to men on active surveillance (co-primary objective B).

Detailed Description: This is a Phase 3, multicentre, open label, randomised controlled study in subjects diagnosed with low risk prostate cancer on TransRectal Ultrasound (TRUS) guided biopsy. Subjects will be randomised to either Active Surveillance or TOOKAD® Soluble VTP. Subjects will remain in the study for approximately 24 months following randomisation. A total of 400 subjects will be entered into the study; 200 will receive Active Surveillance and 200 will receive TOOKAD® Soluble-VTP.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

Dept. of Urology-University Hospitals Leuven, Leuven, , Belgium

Department of Urology-Tampere University Hospital-, Tampere, , Finland

Service d'Urologie - Centre Hospitalier Universitaire d'Angers, Angers, , France

CHRU Hopital Jean Minjoz, Besançon, , France

Site Médipole, Cabestany, , France

Polyclinique Sévigné, Cesson Sévigné, , France

Clinique d'Urologie et de Transplantation Rénale CHU Grenoble, Grenoble, , France

Hôpital Claude Huriez, Lille, , France

Hôpital La Conception, Marseille, , France

Clinique Ambroise Paré, Neuilly sur Seine, , France

Institut Mutualiste Montsouris (IMM), Paris Cedex 14, , France

Hôpital Cochin, Paris Cedex 14, , France

Hôpital Tenon, Paris, , France

Institut Mutualiste Montsouris (IMM), Paris, , France

Centre Hospitalier Universitaire Lyon Sud, Pierre-Bénite, , France

Polyclinique les Bleuets, Reims, , France

CHU Pontchaillou, Rennes, , France

Clinique Urologique Nantes, Saint Herblain, , France

Hôpital Foch, Suresnes, , France

Centre Hospitalier Universitaire de Rangueil, Toulouse, , France

Marien Krankenahaus GmbH, Bergisch Gladbach, , Germany

ATURO-Gemeinschaftspraxis für Urologie und Andrologie, Berlin-Wilmersdorf, , Germany

Klinikum Braunschweig, Braunschweig, , Germany

Universitätsklinikum "Carl Gustav Carus" der Technischen Universität, Dresden, , Germany

Urologische Gemeinschaftspraxis, Emmendingen, , Germany

Martini-Klinik am UKE Hamburg-Eppendorf Prostate Cancer Center, Hamburg, , Germany

Vinzenz Krankenhaus - Department of Urology, Hannover, , Germany

SLK-Kliniken Heilbronn GmbH, Heilbronn, , Germany

University Hospital Schleswig-Holstein, Kiel, , Germany

Ludwig-Maximilians-Universität München, Munich, , Germany

Urologie 24, Nuremberg, , Germany

Unità Operativa Urologia Lucca - c/o Azienda USL 2 - Ospedale Campo di Marte, Lucca, , Italy

Unità di Chirurgia Urologica Mininvasiva, Roma, , Italy

Unità Operativa Urologica di Savona, Ospedale San Paolo di Savona, Savona, , Italy

Osp. S. Giov. Battista Molinette-Dipartimento di Discipline Medico-Chirurgiche Urologia, Torino, , Italy

Netherlands Cancer Institute, Amsterdam, , Netherlands

Polikliniek Urologie-Catharina Ziekenhuis, Eindhoven, , Netherlands

Hospital Universitari de Bellbitge-Servico de Urologia, L'Hospitalet de Llobregat, Barcelona, Spain

Hospital Universitario de A Coruña, A Coruña, , Spain

Fundacio Puigvert-Department of Urology, Barcelona, , Spain

Hospital Vall d'Hebron, Barcelona, , Spain

Department of Urology-Hospital Clinic, University of Barcelona, Barcelona, , Spain

Hospital 12 de Octubre - Departmento de Urologia, Madrid, , Spain

Complejo Hospitalario Regional Virgen Del Rocio-Department Urology, Sevilla, , Spain

Instituto Valenciano de Oncologia, Valencia, , Spain

Dept of Urology-University Hospital-, Malmö, , Sweden

Anna-Seiler-Haus Inselspital, Bern, , Switzerland

Kings College Hospital (KCH), London, , United Kingdom

University College of London Hospital, London, , United Kingdom

Oxford John Radcliffe Hospital Trust, Oxford, , United Kingdom

Royal Hallamshire Hospital, Sheffield, , United Kingdom

Contact Details

Name: Mark Emberton, Professor

Affiliation: University College of London Hospital , United Kingdom

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: